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Klein-Waardenburg syndrome (WS3) 
Waardenburg syndrome with upper limb anomalies 
(WS3) 
White forelock with malformations (WS3) 
Waardenburg-Hirschsprung disease (WS4) 
Waardenburg syndrome variant (WS4) 
Shan-Waardenburg syndrome (WS4) 
Hirschsprung disease with pigmentary anomaly (WS4) 
Note 
Waardenburg syndrome (WS) is an auditory-
pigmentary syndrome caused by a deficiency of 
melanocytes and other neural crest-derived cells. 
The disease was named for Petrus Johannes 
Waardenburg, a Dutch ophthalmologist (1886-1979) 
who was the first to notice that people with two 
different coloured eyes frequently had hearing 
problems. 
Inheritance 
Inherited in an autosomal dominant manner with an 
incidence of 1 in 40 000 newborns. Almost 90% of 
patients have an affected parent but the symptoms in 
the parent can be quite different from those in the c ild. 
Clinics 
Note 
Waardenburg syndrome (WS) is a hereditary auditory-
pigmentary syndrome, the major symptoms being 
congenital sensorineural hearing  
loss and pigmentary disturbance of eyes, hair and skin.
Depending in additional symptoms, WS can be 
classified into four types: WS type I (WS1) is 
associated with facial deformity such as dystopia 
canthorum (lateral displacement of the inner canthi); 
WS2 has no other symptoms; WS3 is associated with 
upper limb deformity; and WS4, with megacolon. 
Phenotype and clinics 
Disease with variable penetrance and several know 
clinical types. Characteristics may include 
depigmentation of the hair and skin, congenital 
deafness, heterochromia iridis, medial eyebrow 
hyperplasia, hypertrophy of the nasal root, and 
especially dystopia canthorum. The underlying cause 
may be defective development of the neural crest 
(neurocristopathy). Waardenburg's syndrome may be 
closely related to piebaldism. Klein-Waardenburg 
syndrome refers to a disorder that also includes upper 
limb abnormalities. 
Neoplastic risk 
Slight increased risk for rhabdomyosarcoma. 
Treatment 
No specific treatment is available for Waardenburg 
syndrome. Attention must be paid to any hearing deficit 
and hearing aids and appropriate schooling may needto 
be provided. Type 4 patients with constipation require 
special attention to their diet and medications to keep 
their bowels moving. 
Prognosis 
With correction of hearing deficits, affected people 
should be able to lead a normal life. 
Genes involved and proteins 
Note 
WS can be classified into for types. At least one gene 
responsible for each type of WS has been cloned and 
for these cloning procedures mice with pigmentation 
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anomalies have contributed greatly. Six genes 
contributing to this syndrome- PAX3, SOX10, MITF, 
SLUG, EDN3 and EDNRB- have been cloned so far, 






PAX3 is an important gene in muscle development and 
muscle-producing neoplasms such as 
rhabdomyosarcomas. 
DNA/RNA 
Description: 10 exons. 
Protein 
Description: 206-215 residues. 
Expression: is expressed during embryonic 
development. Skeletal muscle, esophagus, cerebellum, 
pancreas, liver and stomach. 
Function: Transcription factor. 
Mutations 
Mutations in PAX3, which encodes a paired 
homeodomain transcription factor, are responsible for 
Waardenburg syndrome 1 and 3.  
PAX3 was shown to bind and transactivate the MITF 
promoter, thereby demonstrating the role of PAX3 in 
the regulation of MITF expression. This observation 
supports an epistatic relationship between MITF and
PAX3 and can explain the pigmentary disorders 
observed in WS1 and 3, because MITF controls 
melanocyte development. PAX3 defects affect neural 








Description: 5 exons. 
Protein 
SOX10, a protein that modulates other transcription 
factors (including PAX3) belongs to the high mobility 
group (HMG) box superfamily of DNA-binding 
proteins. It is first expressed during development in 
cells of the neural crest that contributes to the forming 
peripheral nervous system, and can be detected in the 
sensory, sympathetic and enteric ganglia and along 
nerves. SOX10 is also transiently expressed in 
melanoblast. 
Description: 466 residues. 
Expression: During development in cells of the neural 
crest. 
Function: Transcription factor. 
Mutations 
Mutations in Sox10 also result in WS4. 
How mutations in this gene lead to deafness and 
pigmentary abnormalities, shared by all the WS 
subtypes, was not elucidated. It was tempting to 
propose that the WS4 genes are directly or indirectly 
involved in the regulation of MITF expression that is 
crucial for melanocyte development. 
SOX10 binds and transactivates the MITF promoter, 
whereas Sox10 mutants found in WS4 patients failed to 
stimulate the MITF promoter. Thus, there is an epistatic 
relationship between SOX1 and MITF, thereby giving a 
molecular basis for the audio-pigmentary defect in 
patients with WS4. 
SOX10 joins Pax3, CREB and LEF1 in the list of 
transcription factors that control MITF expression. 
 
 
GENE Syndrome Specific symptoms 
PAX3 WS1; WS3 Dysthopia canthorum, hypoplasia of limb muscle; contracture of elbows, 
fingers. 
MITF WS2 Main symptoms only (auditory-pigmentary syndrome) 
SLUG WS2 Main symptoms only (auditory-pigmentary syndrome) 
EDNRB WS4 Hirschsprung’s disease 
EDN3 WS4 Hirschsprung’s disease 
SOX10 WS4 Hirschsprung’s disease 
 





















Description: 9 exons. 
Protein 
Microphtalmia-associated transcription factor (MITF) 
is a basic helix-loop-helix, leucin zipper transcription 
factor that plays a pivotal role in survival and 
differentiation of melanocytes, the cells that produce 
melanin pigments. MITF has been demonstrated to up-
regulate the expression of the genes involved in 
melanin synthesis, such as tyrosine, TRP1, and TRP2. 
Further MITF is thought to be a master gene in 
melanocyte differentiation, because its forced 
expression in fibroblast leads to the expression of 
melanocytes-specific enzymes required for melanin 
synthesis. 
Description: 520 residues. 
Expression: in melanocytes. 
Function: Transcription factor. 
Mutations 
In humans, mutations, of MITF are responsible for 
Waardenburg syndrome (WS) type 2, characterized by 
pigmentation abnormalities and sensorineural deafness 
due to the absence of melanocytes from the stria 
vascularis of the inner ear. 
In mice, mutations in the microphthalmia gene cause 
pigmentation disorders because of the absence of 
melanocytes, supporting the involvement of MITF in 
melanocyte survival.  
Over 20 different Mitf mutations have been described 
in mice. They all result in a deficiency in skin or coat 
melanocytes ranging in severity from minor pigmentary 
defects with normal eyes to total lack of coat and eye
pigmentation, small colobomatous eyes, deafness and 





Description: 3 exons. 
Protein 
SLUG a zinc finger transcription factor is a marker of 
neural crest cells in Xenopus, zebrafish and chick 
embryos and probably has a functional role in 
formation of premigratory neural crest. In the mouse, 
the corresponding gene, Slugh, is expressed in 
migratory but not premigratory neural crest cells and is 
not essential for neural crest development. 
Description: 268 residues. 
Expression: Placenta, adult heart, pancreas, liver, 
kidney and skeletal muscle. 
Function: Transcriptional repressor. 
 
Mutations 
Mice lacking Slugh have patchy deficiency of 
melanocytes, a phenotype similar to human 
Waardenburg syndrome. It has been shown that some 
human patients with Waardenburg syndrome carry 
homozygous deletions of SLUG as their only detected 
genetic abnormality, thus defining a recesive form of 
type 2 WS. Preliminary investigations of the role of 
SLUG in melanocyte development show that it is a 
downstream target of MITF, which acts on an E-box 
sequence in the SLUG promoter. 




Description: 5 exons. 
Protein 
Description: 230 residues. 
Expression: Trophoblasts, placental stem villi vessels. 
Function: Peptide hormone. 





Description: 7 exons. 
Protein 
Description: 442 residues. 
Expression: lung, placenta, kidney and skeletal muscle. 
Function: G protein-coupled receptor. 
Mutations 
WS4 is also caused by mutations in endothelin B 
receptor or in endothelin 3. How mutations in these 
genes lead to deafness and pigmentary abnormalities, 
shared by all the WS subtypes, was not elucidated. I  
was tempting to propose that the WS4 genes are 
directly or indirectly involved in the regulation of 
MITF expression that is crucial for melanocyte 
development. 
To be noted 
Mouse models 
Mutant mice with coat color anomalies were helpful in 
identifying these genes, although the phenotypes of 
these mice did not necessarily perfectly match those of 
the four types of WS. There are several mice with 
mutations of murine homologs of WS genes and verify 
their suitability as models for WS with special interest 
in the cochlear disorder. The mice include splotch (Sp), 
microphthalmia (mi), Slugh -/-, WS4, JF1, lethal-
spotting (ls), and Dominant megacolon (Dom). 
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splotch (Sp) mice as a model for WS1 
The mouse Pax3 gene was identified as the gene 
responsible for splotch (Sp) mice. Sp mice exhibit a 
number of characteristic developmental anomalies 
which predominantly affect the neural tube and neural 
crest. Severe alleles in six types of homozygous Sp 
mice are fatal at the embryonic stage, and even splotch-
retarded (Spd) mice, which have the least severe allele, 
encoding Pax3 with a substitution mutation at the 
paired domain, die at birth. Heterozygous Sp (Sp/+) 
mice survive after birth and have white belly spots, but 
curiously, showed no sign of auditory defects; WS1 
patients are usually heterozygous at the PAX3 gene and 
yet many show auditory dysfunction. The phenotype of 
Spd mice varies depending on their genetic 
background, suggesting the existence of modifier 
genes. It has been estimated that at least two genes 
interact with Spd to influence the craniofacial features. 
microphthalmia (mi) mice as a model for WS2 
Homozygous mi mice are microphthalmic due to the 
loss of retinal pigmentary epithelial (RPE) cells, white 
in coat color due to the loss of melanocytes, and deaf.  
11 types of mi gene mutations, so far identified in mi 
mice, are transmitted in either a recesive or semi-
dominant manner. In contrast, in humans is transmitted 
in a dominant manner. 
Slugh-/- mice as a model for WS2  
Slugh-/- mice have diluted coat color, a white forehead 
blaze, and areas of depigmentation on the ventral body, 
tail and feet. Hearing function has not yet been asses ed 
in Slugh-/- mice, but hyperactivity and circling 
behaviours observed in some Slugh-/- mice suggest a 
vestibule-cochlear disorder. 
WS4 mice as a model for WS4  
Homozygous WS4 mice showed pigmentation anomaly 
(white coat color with black eye), aganglionic 
megacolon and cochlear disorder. Exons 2 and 3, which 
encode transmembrane domains III and IV of the Ednrb 
G-protein-coupled receptor protein, were deleted in 
these mice. Cochlea of WS4 mice showed 
endolymphatic collapse, due to the lack of melanocytes 
(intermediate cells) in the stria vascularis. 
JF1 mice as a model for WS2 
The JF1 mice are an inbred strain of mice derived from 
Japanese wild mice, which are often bred by Japanese 
laymen as fancy „panda¾ mice because of their cute 
appearance with black eyes and white spotting on a 
black coat. JF1 mice are not lethal even in the 
homozygous state. This non-lethality of JF1 mice is 
probably due to the fact that the mutation in mice is an 
insertional mutation in intron 1 that creates a cryptic 
splicing acceptor site that results in decreased 
expression of wild-type Ednrb but does not cause 
aganglionic megacolon. As JF1 mice have 
pigmentation anomalies and hearing impairment- but 
not megacolon or dysmorphogenesis- they constitute a 
mouse model of WS2. These notions are consistent 
with the finding that WS2 is occasionally caused by 
mutations in EDNRB. 
lethal-spotted (ls) mice as a model for WS4 
Homozygous mutations of the endothelin 3 (EDN3) 
gene cause coat spotting and aganglionic megacolon in 
ls mice and gene targeted edn3 null mice. Some of 
these mice can survive and mate; they are potentially a 
model for WS4, although cochlear disorders of these 
mice remain to be examined. 
Dominant megacolon (Dom) mice as a model for 
WS4 
The Sox10 gene is mutated in the dominant megacolon 
(Dom) mouse, an animal model of neurocristopathy, 
whose phenotype is reminiscent of Waardenburg-
Hirschsprung patients. The pigmentary phenotype also
suggests that Sox10 expression is essential for 
melanocyte development. 
Homozygous Dom mice are lethal and their embryos 
lack neural crest-derived cells expressing the 
melanocyte lineage markers. Heterozygous Dom mice 
show white spotting and some of them show 
megacolon. Dom mice not respond to sound. They did 
not show endolymphatic collapse, suggesting that their 
stria vascularis had intermediate cells (melanocytes) 
sufficient for normal production of endolymph. 
However, their organ of Corti was missing. 
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